Apellis Pharmaceuticals, Inc. (APLS)
21.03
+0.56
(+2.74%)
USD |
NASDAQ |
Jan 21, 10:28
Apellis Pharmaceuticals Total Assets (Quarterly): 1.059B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 868.81M |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Ionis Pharmaceuticals, Inc. | 3.033B |
| Fortress Biotech, Inc. | 181.41M |
| Sarepta Therapeutics, Inc. | 3.493B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 657.56M |
| Shareholders Equity (Quarterly) | 401.17M |
| Debt to Equity Ratio | 1.185 |
| Current Ratio | 3.544 |
| Net Debt Paydown Yield | -0.01% |